FHIT and lung carcinoma: Gaudio E et al. [32] reported that the Fhit protein can interact with ANXA4 and that Fhit overexpression prevents ANXA4 translocation from the cytosol to the plasma membrane in A549 lung cancer cells treated with paclitaxel.